You are here

cystic fibrosis

ReCode Raises $260M in Series B Financing to Advance Lead Programs

ReCode Raises $260M in Series B Financing to Advance Lead Programs

BioSpace

ReCode Therapeutics

primary ciliary dyskinesia

cystic fibrosis

Flag link:

Vertex Pharma raises full-year revenue forecast on cystic fibrosis treatment strength

Vertex Pharma raises full-year revenue forecast on cystic fibrosis treatment strength

Yahoo/Reuters

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

ReCode, Vertex and 4DMT Seek to Help Untreated Cystic Fibrosis Patients

ReCode, Vertex and 4DMT Seek to Help Untreated Cystic Fibrosis Patients

BioSpace

cystic fibrosis

Vertex Pharmaceuticals

Flag link:

First Wave completes patient screening in trial of cystic fibrosis therapy

First Wave completes patient screening in trial of cystic fibrosis therapy

Clinical Trials Arena

First Wave Biopharma

clinical trials

cystic fibrosis

Flag link:

This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?

This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?

Motley Fool

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Spotlight – Cystic fibrosis developers take a deep breath

Spotlight – Cystic fibrosis developers take a deep breath

EP Vantage

cystic fibrosis

Vertex Pharmaceuticals

4D Molecular Therapeutics

Arcturus Therapeutics

Arrowhead Pharmaceuticals

Boehringer Ingelheim

Eloxx Pharmaceuticals

Krystal Biotech

Moderna Therapeutics

Oxford BioMedica

ReCode Therapeutics

Sumitomo Pharmaceuticals

Tessera Therapeutics

Flag link:

‘Caught in the middle’: A battle between Vertex and insurers is leaving cystic fibrosis patients with crushing drug costs

‘Caught in the middle’: A battle between Vertex and insurers is leaving cystic fibrosis patients with crushing drug costs

Stat

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Vertex pricing under fire—again—as activists press 4 governments for Trikafta generics

Vertex pricing under fire—again—as activists press 4 governments for Trikafta generics

Fierce Pharma

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

First Wave BioPharma to initiate trial of adrulipase for cystic fibrosis

First Wave BioPharma to initiate trial of adrulipase for cystic fibrosis

Clinical Trials Arena

First Wave Biopharma

clinical trials

cystic fibrosis

Flag link:

NIH-Supported Clinical Trial of Phage Therapy for Cystic Fibrosis Begins

NIH-Supported Clinical Trial of Phage Therapy for Cystic Fibrosis Begins

Drugs.com

clinical trials

cystic fibrosis

Adaptive Phage Therapeutics

Flag link:

Why Vertex Pharmaceuticals' Shares Rose 2.8% in September

Why Vertex Pharmaceuticals' Shares Rose 2.8% in September

Motley Fool

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Where Will Vertex Pharmaceuticals Be in 1 Year?

Where Will Vertex Pharmaceuticals Be in 1 Year?

Motley Fool

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Fueled by $111 Million, Sionna Therapeutics Takes Aim at Cystic Fibrosis

Fueled by $111 Million, Sionna Therapeutics Takes Aim at Cystic Fibrosis

BioSpace

Sionna Therapeutics

cystic fibrosis

Vertex Pharmaceuticals

Flag link:

Vertex’s Robust Pipeline is Ramping Up for Another Big Year

Vertex’s Robust Pipeline is Ramping Up for Another Big Year

BioSpace

Vertex Pharmaceuticals

cystic fibrosis

sickle cell disease

type 1 diabetes

Flag link:

Vertex strikes agreement with Australia for cystic fibrosis pill, ending high-profile standoff

Vertex strikes agreement with Australia for cystic fibrosis pill, ending high-profile standoff

Endpoints

cystic fibrosis

Flag link:

New OrbiMed-backed biotech aims to replicate Vertex's wildly successful cystic fibrosis pills in other diseases

New OrbiMed-backed biotech aims to replicate Vertex's wildly successful cystic fibrosis pills in other diseases

Endpoints

Congruence Therapeutics

Vertex Pharmaceuticals

protein misfolding

cystic fibrosis

Flag link:

3 Clinical Trials to Watch in the First Half of 2022

3 Clinical Trials to Watch in the First Half of 2022

Motley Fool

clinical trials

Arena Pharmaceuticals

Alzheimer's disease

cystic fibrosis

Flag link:

JPM 2022: Vertex's Trikafta holds the line as company lays groundwork for gene editing launch

JPM 2022: Vertex's Trikafta holds the line as company lays groundwork for gene editing launch

Fierce Pharma

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Cystic fibrosis group partners with Moderna founder to find better, potentially curative treatments

Cystic fibrosis group partners with Moderna founder to find better, potentially curative treatments

BioPharma Dive

patient advocacy groups

Flagship Pioneering

Moderna Therapeutics

cystic fibrosis

Flag link:

Could This Drug Become Vertex Pharmaceuticals' Next Blockbuster?

Could This Drug Become Vertex Pharmaceuticals' Next Blockbuster?

Motley Fool

Vertex Pharmaceuticals

cystic fibrosis

clinical trials

type 1 diabetes

Flag link:

Pages